Table 2.
Interferon |
Common (≥10%) |
Mild bone marrow suppression (anaemia, leucopaenia, thrombocytopaenia) |
Depression |
Insomnia |
Fatigue and irritability |
Weight loss/anorexia |
Fever, myalgia, headaches, and flu-like symptoms |
Injection-site irritation |
Nausea/vomiting and diarrhoea |
Occasional (2–9%) |
Retinopathy (usually not clinically significant) |
Exacerbation of autoimmune condition (e.g. hepatitis, thyroiditis, rheumatoid arthritis, psoriasis) |
Congestive heart failure and arrhythmias |
Rare (≤1%) |
Severe bone marrow depression |
Seizures |
Tinnitus and hearing loss |
Hyperglycaemia |
Renal failure |
Pneumonitis |
Ribavirin |
Common (≥10%) |
Haemolytic anaemia (dose dependent) |
Fatigue |
Rash and pruritis |
Nasal stuffiness |
Cough |
‘Hepatitis C: a review for primary care physicians’. Adapted from CMAJ; 174: 649–659 by permission from the publisher. © Canadian Medical Association (107).